Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome [NA]

View source ↗

Summary

A clinical trial update for ripertamab in children with frequent relapses or steroid-dependent nephrotic syndrome; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ripertamab

Snippet

Sponsor: Mao Jianhua | Conditions: FRNS/SDNS, Ripertamab | NA | Status: NOT_YET_RECRUITING